FANJ
GCVRZ

Financial Architects (New Jersey)’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Financial Architects (New Jersey)’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-402
Closed – – 1544
2016
Q1 		$0 Buy
+402
New +$44 ﹤0.01% 1183

Other funds holding GCVRZ

SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
CPM
Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return
NGA
New Generation Advisors Manchester, Massachusetts $45.6M AUM 15.43% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
MFP
Michael F. Price $846M AUM 0.07% 1-Year Est. Return

Financial Architects (New Jersey)'s GCVRZ Position: Q2 2016 in Review

Financial Architects (New Jersey) sold out of Sanofi Contingent Value Rights (GCVRZ) in Q2 2016, closing a stake of 402 shares.

Financial Architects (New Jersey) first reported a position in GCVRZ in Q1 2016 and held it in 1 quarter. The position peaked at $0 in Q1 2016. 109 funds tracked by Wall St. Rank hold GCVRZ as of Q2 2016.

  • Financial Architects (New Jersey) reported no remaining Sanofi Contingent Value Rights position as of Q2 2016 after selling out during the quarter.
  • Financial Architects (New Jersey) sold 402 Sanofi Contingent Value Rights shares in Q2 2016.
  • Financial Architects (New Jersey) first reported a position in Sanofi Contingent Value Rights in Q1 2016 and held it in 1 quarter.
  • Financial Architects (New Jersey)'s Sanofi Contingent Value Rights position peaked at $0 in Q1 2016.
  • 109 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q2 2016.

Based on Financial Architects (New Jersey)'s 13F filing for Q2 2016, filed 25 Jul 2016.